Literature DB >> 10423530

Up-regulation of telomerase in primary cultured rat hepatocytes.

K Nozawa1, Y Kurumiya, A Yamamoto, Y Isobe, M Suzuki, S Yoshida.   

Abstract

Telomerase is a unique reverse transcriptase involved in the maintenance of telomeric DNA, which is generally undetectable in normal human somatic cells. However, it has been found in organs of normal adult rodents including the liver. In order to elucidate relevant control mechanisms operating in normal somatic cells, we examined telomerase activity in primary cultured rat hepatocytes. During culture under serum-free conditions, rat hepatocytes rapidly lose the ability of organ-specific expression of serum albumin, apolipoprotein A-I, and hepatocyte nuclear factor 4, and the capacity for cytochrome P-450 induction by xenobiotics. The telomerase activity was found to be concomitantly increased about 2. 5-fold at 48 h and 3-fold at 72 h. Northern blot and RT-PCR analyses with primary cultured hepatocytes revealed the associated accumulation of rat telomerase RNA subunits (TR), and the mRNAs for a telomerase reverse transcriptase (TERT) and a telomerase-associated protein (TEP1). The activity of hepatocyte telomerase, which was elevated during the primary culture, increased further when the cells were stimulated with hepatocyte growth factor. In this case, however, the levels of TR, TERT, and TEP1 mRNA did not show any detectable changes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423530     DOI: 10.1093/oxfordjournals.jbchem.a022458

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

Review 1.  Liver regeneration.

Authors:  George K Michalopoulos
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

2.  Biological and clinical insights offered by chemically induced liver progenitors (CLiPs).

Authors:  Takeshi Katsuda; Takahiro Ochiya
Journal:  Stem Cell Investig       Date:  2017-08-21

3.  Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.

Authors:  De-xiu Bu; Maria E Johansson; Jingyi Ren; Da-wei Xu; F Brad Johnson; Kristina Edfeldt; Zhong-qun Yan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-23       Impact factor: 8.311

4.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

5.  Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin.

Authors:  Yogesh-K Vashist; Celine Tiffon; Christoforos Stoupis; Claudio-A Redaelli
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

Review 6.  Liver regeneration: alternative epithelial pathways.

Authors:  George K Michalopoulos
Journal:  Int J Biochem Cell Biol       Date:  2009-09-27       Impact factor: 5.085

Review 7.  Mesenchymal stem cell therapy for liver fibrosis.

Authors:  Young Woo Eom; Kwang Yong Shim; Soon Koo Baik
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

Review 8.  Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.

Authors:  Kyeong-Ah Kwak; Hyun-Jae Cho; Jin-Young Yang; Young-Seok Park
Journal:  Can J Gastroenterol Hepatol       Date:  2018-01-29

9.  Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.

Authors:  Toru Shimazui; Yoshihiro Ami; Naoto Miyanaga; Yukitaka Ideyama; Takahito Nakahara; Hideyuki Akaza
Journal:  Jpn J Cancer Res       Date:  2002-05

Review 10.  Strategies for immortalization of primary hepatocytes.

Authors:  Eva Ramboer; Bram De Craene; Joery De Kock; Tamara Vanhaecke; Geert Berx; Vera Rogiers; Mathieu Vinken
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.